Megan Dover

Junior Partner & Co-Founder

Cross Border Impact Ventures

Megan Dover, Co-founder & Junior Partner of Cross Border Impact Ventures (CBIV), has in depth experience in impact investing, angel investing, venture advisory, M&A, business strategy and Financial Planning & Analysis. At CBIV, she invests in Series A stage health technology companies in North America and Europe that address unmet needs for women and children globally. Prior to the launch of the firm, she was a venture advisor to a portfolio of impact first health technology companies and mobilized $46 million in equity and non dilutive capital for the portfolio. Megan has also held senior level roles in corporate finance and strategy for a publicly traded mining and infrastructure company, worked in management consulting for a global consulting firm, worked in R&D for a biotech startup and acted as an advisor and angel investor at the Creative Destruction Lab (CDL) in Toronto. Megan obtained her MBA from the Rotman School of Management at the University of Toronto, receiving a Dean’s list ranking. She also earned her Engineering degree with Honours from Queen’s University, specializing in Biomedical Research within Chemical Engineering.